Misoprostol administration prior to intrauterine contraceptive device insertion: a systematic review and meta-analysis of randomised controlled trials

References

• Bühling KJ, Zite NB, Lotke P, et al. Worldwide use of intrauterine contraception: a review. Contraception 2014;89:162–173.
   PubMed Web of Science ®Google Scholar
• Bahamondes MV, Espejo-Arce X, Bahamondes L. Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT. Hum Reprod. 2015;30:1861–1866.
   PubMed Web of Science ®Google Scholar
• ESHRE Capri Workshop Group. Intrauterine devices and intrauterine systems. Hum Reprod Update. 2008;14:197–208.
   PubMed Web of Science ®Google Scholar
• Clegg JP, Guest JF, Hurskainen R. Cost–utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK. Curr Med Res Opin. 2007;23:1637–1648.
   PubMed Web of Science ®Google Scholar
• Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2006;2:CD003855.
   Google Scholar
• Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004;291:1456–1463.
   PubMed Web of Science ®Google Scholar
• Kulier R, Kapp N, Gülmezoglu AM, et al. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2011;11:CD002855.
   PubMed Web of Science ®Google Scholar
• Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007;99:S160–S167.
   PubMed Web of Science ®Google Scholar
• Batukan C, Ozgun MT, Ozcelik B, et al. Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostol. Fertil Steril. 2008;89:966–973.
   PubMed Web of Science ®Google Scholar
• Allen RH, Board of Society of Family Planning, Goldberg AB. Cervical dilation before first-trimester surgical abortion (<14 weeks' gestation). SFP Guideline 20071. Contraception 2007;76:139–156.
   PubMed Web of Science ®Google Scholar
• Zhuo Z, Yu H, Jiang X. A systematic review and meta-analysis of randomized controlled trials on the effectiveness of cervical ripening with misoprostol administration before hysteroscopy. Int J Gynaecol Obstet. 2016;132:272–277.
   PubMed Web of Science ®Google Scholar
• Wu HL, Marwah S, Wang P, et al. Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis. Sci Rep. 2017;7:1664.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Cochrane Bias Methods Group, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928–d5928.
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–1101.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557–560.
   PubMed Web of Science ®Google Scholar
• Moher D, The PRISMA Group, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Rasheedy R, Tamara TF, Allam IS, et al. Vaginal misoprostol before copper IUD insertion after previous insertion failure: a double-blind, placebo-controlled, parallel-group, randomised clinical trial. Eur J Contracept Reprod Health Care. 2019;24:222–226.
   PubMed Web of Science ®Google Scholar
• Ibrahim ZM, Sayed Ahmed WA. Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. Eur J Contracept Reprod Health Care. 2013;18:300–308.
   PubMed Web of Science ®Google Scholar
• Edelman AB, Schaefer E, Olson A, et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception 2011;84:234–239.
   PubMed Web of Science ®Google Scholar
• Maged AM, Youssef G, Eldaly A, et al. Benefits of vaginal misoprostol prior to IUD insertion in women with previous caesarean delivery: a randomised controlled trial. Eur J Contracept Reprod Health Care. 2018;23:32–37.
   PubMed Web of Science ®Google Scholar
• Abdellah MS, Abbas AM, Hegazy AM, et al. Vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective cesarean section: a randomized double-blind clinical trial. Contraception 2017;95:538–543.
   PubMed Web of Science ®Google Scholar
• Sääv I, Aronsson A, Marions L, et al. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod. 2007;22:2647–2652.
   PubMed Web of Science ®Google Scholar
• Scavuzzi A, Souza ASR, Costa AAR, et al. Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Hum Reprod. 2013;28:2118–2125.
   PubMed Web of Science ®Google Scholar
• Lathrop E, Haddad L, McWhorter CP, et al. Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception 2013;88:725–729.
   PubMed Web of Science ®Google Scholar
• Espey E, Singh RH, Leeman L, et al. Misoprostol for intrauterine device insertion in nulliparous women: a randomized controlled trial. Am J Obstet Gynecol. 2014;210:208.e1–208.e5.
   Web of Science ®Google Scholar
• Dijkhuizen K, Dekkers OM, Holleboom CA, et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod. 2011;26:323–329.
   PubMed Web of Science ®Google Scholar
• Swenson C, Turok DK, Ward K, et al. Self-administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstet Gynecol. 2012;120:341–347.
   PubMed Web of Science ®Google Scholar
• Heikinheimo O, Inki P, Kunz M, et al. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception 2010;81:481–486.
   PubMed Web of Science ®Google Scholar
• Lotke PS, Tiwari A, Leybas NV. Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. Am J Clin Exp Obstet Gynecol 2013;1:62–68.
   Google Scholar
• Preutthipan S, Herabutya Y. A randomized comparison of vaginal misoprostol and dinoprostone for cervical priming in nulliparous women before operative hysteroscopy. Fertil Steril. 2006;86:990–994.
   PubMed Web of Science ®Google Scholar
• Waddell G, Desindes S, Takser L, et al. Cervical ripening using vaginal misoprostol before hysteroscopy: a double-blind randomized trial. J Minim Invasive Gynecol. 2008;15:739–744.
   PubMed Web of Science ®Google Scholar
• Oppegaard KS, Nesheim BI, Istre O, et al. Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design. BJOG. 2008;115:663e1–663e9.
   Google Scholar
• el-Refaey H, Rajasekar D, Abdalla M, et al. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med. 1995;332:983–987.
   PubMed Web of Science ®Google Scholar
• Danielsson KG, Marions L, Rodriguez A, et al. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol. 1999;93:275–280.
   PubMed Web of Science ®Google Scholar
• Arias F. Pharmacology of oxytocin and prostaglandins. Clin Obstet Gynecol. 2000;43:455–468.
   PubMed Web of Science ®Google Scholar
• Khalaf M, Amin AF, Sayed Z, et al. A randomized double-blind controlled trial of two different doses of self-administered vaginal misoprostol for successful copper intrauterine device insertion. Middle East Fertil Soc J. 2017;22:264–268.
   Web of Science ®Google Scholar
• Barnett C, Moehner S, Do Minh T, et al. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study. Eur J Contracept Reprod Health Care. 2017;22:424–428.
   PubMed Web of Science ®Google Scholar
• Grandi G, Farulla A, Sileo FG, et al. Levonorgestrel-releasing intra-uterine systems as female contraceptives. Expert Opin Pharmacother. 2018;19:677–686.
   PubMed Web of Science ®Google Scholar
• Choksuchat C. Clinical use of misoprostol in nonpregnant women: review article. J Minim Invasive Gynecol. 2010;17:449–455.
   PubMed Web of Science ®Google Scholar
• Fernandez H, Alby JD, Tournoux C, et al. Vaginal misoprostol for cervical ripening before operative hysteroscopy in pre-menopausal women: a double-blind, placebo-controlled trial with three dose regimens. Hum Reprod. 2004;19:1618–1621.
   PubMed Web of Science ®Google Scholar
• Hua Y, Zhang W, Hu X, et al. The use of misoprostol for cervical priming prior to hysteroscopy: a systematic review and analysis. Dddt. 2016;10:2789–2801.
   PubMed Web of Science ®Google Scholar